SUNScholar will be down for routine maintenance from 2018-12-11 10:00 SAST.

Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults

Gbabe, O. F. ; Okwundu, C. I. ; Dedicoat, M. ; Freeman, E. E. (2014)

CITATION: Gbabe, O. F. et al. 2014. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults. Cochrane Database of Systematic Reviews, 9: CD003256, doi:10.1002/14651858.CD003256.pub2.

The original publication is available at https://www.cochranelibrary.com

Article

Background: Kaposi’s sarcoma remains the most common cancer in Sub-Saharan Africa and the second most common cancer in HIV-infected patients worldwide. Since the introduction of highly active antiretroviral therapy (HAART), there has been a decline in its incidence. However, Kaposi’s sarcoma continues to be diagnosed in HIV-infected patients. Objectives: To assess the added advantage of chemotherapy plusHAART compared toHAART alone; and the advantages of different chemotherapy regimens in HAART and HAART naive HIV infected adults with severe or progressive Kaposi’s sarcoma.

Please refer to this item in SUNScholar by using the following persistent URL: http://hdl.handle.net/10019.1/104447
This item appears in the following collections: